98%
921
2 minutes
20
Background And Objectives: Trigeminal Neuralgia (TN) is a debilitating facial pain disorder, often necessitating surgical interventions when medication proves insufficient. Stereotactic Radiosurgery (SRS) is an established therapeutic option. Limited studies explored the feasibility of a third SRS procedure. Our study investigates the safety and efficacy of a third SRS procedure for recurrent TN.
Methods: We performed a retrospective analysis across multiple centers using databases collected prospectively. Pain status was evaluated utilizing the BNI Pain Intensity Scales. The Kaplan-Meier method was employed to estimate the time to recurrence, with group comparisons conducted using log-rank tests. Associations were explored using Chi-square and logistic regression models.
Results: Ten institutions contributed with a total of 35 patients. A third SRS revealed sustained effectiveness with a pain control rate of 82.7%. The median time to recurrence was 35.5 months. New sensory dysfunction following the third procedure occurred in 22% of patients who had preserved sensory function after the second procedure. When considering those who developed sensory dysfunction after the second procedure, 40% of the entire cohort was affected. There were no significant differences in pain recurrence intervals among the three procedures. A meta-analysis, combining data from previous studies, showed that 89.6% of patients achieved some degree of pain control after a third SRS, with 27.4% experiencing new sensory dysfunction and a median time to recurrence of 31.6 months.
Conclusion: Our study, the largest on the topic, affirms the sustained effectiveness of a third SRS for TN, providing comparable pain relief to initial procedures. Notably, an extended pain-free interval after the third SRS session was observed. Facial sensory dysfunction emerged as the primary side effect. Larger studies are warranted to explore correlations with demographics and treatment parameters for a comprehensive understanding of repeat SRS in managing recurrent TN.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00701-024-06317-2 | DOI Listing |
Clin Exp Metastasis
September 2025
Department of Neurosurgery, Warren Alpert Medical School of Brown University, 593 Eddy Street - APC 6, Providence, RI, 02903, USA.
Significant variability exists in the use of corticosteroids for treating adverse radiation effects (ARE) after stereotactic radiosurgery (SRS) of brain metastasis (BM). Here, we determine the diagnostic utility of a quadrant-based, visual assessment of magnetic resonance (MR) FLAIR as an imaging biomarker for steroid-dependent ARE. FLAIR was assessed at four axial levels along the rostral-caudal axis of the cerebrum, defined by standard landmarks of superior temporal line, third ventricle, temporal horn, and fourth ventricle.
View Article and Find Full Text PDFCan Urol Assoc J
August 2025
Minneapolis VA Healthcare System, Minneapolis, MN, United States.
Introduction: We aimed to evaluate whether generative large language models (LLMs) can accurately assess the methodologic quality of systematic reviews (SRs).
Methods: A total of 114 SRs from five leading urology journals were included in the study. Human reviewers graded each of the SRs in duplicates, with differences adjudicated by a third expert.
Cureus
July 2025
Neurological Surgery, Jersey Shore University Medical Center, Neptune, USA.
Stereotactic radiosurgery (SRS) is an established modality for managing spinal tumors, offering targeted radiation while preserving adjacent critical structures. The ZAP-X gyroscopic SRS system (ZAP Surgical Systems, Inc., San Carlos, CA) introduces a novel, self-shielded, non-isocentric platform that may expand access to SRS and streamline treatment delivery.
View Article and Find Full Text PDFRadiother Oncol
August 2025
Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Introduction: We present the first-in-human application of stereotactic radiosurgery (SRS) targeting the left stellate ganglion (LSG) as a non-invasive neuromodulatory strategy for treating polymorphic ventricular tachycardia/ventricular fibrillation (VT/VF).
Materials And Methods: A 69-year-old man with mixed-etiology cardiomyopathy (LVEF 28 %) experienced 27 VT/VF episodes over three months. This resulted in 18 implantable cardioverter-defibrillator (ICD) shocks and nine anti-tachycardia pacing therapies, despite optimal pharmacotherapy, catheter ablation and two temporary LSG blocks.
Cureus
June 2025
Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Background and purpose Volumetric modulated arc therapy (VMAT) with a C-arm linear accelerator has been adopted for stereotactic radiosurgery (SRS) for treating brain tumors. Some treatment planning systems (TPSs) generate sequences that align the jaw with the edge of the multileaf collimator (MLC) radiation field during VMAT. However, the jaw exhibits greater geometric positioning uncertainty than the MLC.
View Article and Find Full Text PDF